Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prostate MRSI predicts outcome in radical prostatectomy patients.
Zakian KL, Hatfield W, Aras O, Cao K, Yakar D, Goldman DA, Moskowitz CS, Shukla-Dave A, Tehrani YM, Fine S, Eastham J, Hricak H. Zakian KL, et al. Among authors: aras o. Magn Reson Imaging. 2016 Jun;34(5):674-81. doi: 10.1016/j.mri.2016.01.003. Epub 2016 Jan 26. Magn Reson Imaging. 2016. PMID: 26821278 Free PMC article.
Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology.
Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, Mena E, Daar D, Rastinehad AR, Linehan WM, Wood BJ, Pinto PA, Choyke PL. Turkbey B, et al. Among authors: aras o. J Magn Reson Imaging. 2014 Jun;39(6):1443-8. doi: 10.1002/jmri.24317. Epub 2013 Nov 15. J Magn Reson Imaging. 2014. PMID: 24243824 Free PMC article.
Simultaneous injection of 18F-BF3- Cy3-ACUPA and non-radioactive Cy7-ACUPA probes: a promising pre-biopsy PET and ex vivo fluorescence imaging approach to evaluate prostate cancer.
Aras O, Demirdag C, Kommidi H, Pavlova I, Boyko V, Lundon DJ, Ting R, Tewari A, Akin O, Sayman HB. Aras O, et al. Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3732-3733. doi: 10.1007/s00259-021-05344-w. Epub 2021 Apr 16. Eur J Nucl Med Mol Imaging. 2021. PMID: 33860854 Free PMC article. No abstract available.
Correlation of magnetic resonance imaging tumor volume with histopathology.
Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, Pohida T, Daar D, Benjamin C, McKinney YL, Linehan WM, Wood BJ, Merino MJ, Choyke PL, Pinto PA. Turkbey B, et al. Among authors: aras o. J Urol. 2012 Oct;188(4):1157-1163. doi: 10.1016/j.juro.2012.06.011. Epub 2012 Aug 15. J Urol. 2012. PMID: 22901591 Free PMC article.
Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?
Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL. Turkbey B, et al. Among authors: aras o. Radiology. 2013 Jul;268(1):144-52. doi: 10.1148/radiol.13121325. Epub 2013 Mar 6. Radiology. 2013. PMID: 23468576 Free PMC article.
Complicated pubovesical fistula on PET/CT and MRI.
Aras O, Sayman HB. Aras O, et al. Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3335-3336. doi: 10.1007/s00259-021-05305-3. Epub 2021 Mar 19. Eur J Nucl Med Mol Imaging. 2021. PMID: 33742237 No abstract available.
Small Molecule, Multimodal, [18F]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study.
Aras O, Demirdag C, Kommidi H, Guo H, Pavlova I, Aygun A, Karayel E, Pehlivanoglu H, Yeyin N, Kyprianou N, Chen N, Harmsen S, Sonmezoglu K, Lundon DJ, Oklu R, Ting R, Tewari A, Akin O, Sayman HB. Aras O, et al. Clin Genitourin Cancer. 2021 Oct;19(5):405-416. doi: 10.1016/j.clgc.2021.03.011. Epub 2021 Mar 19. Clin Genitourin Cancer. 2021. PMID: 33879400 Free PMC article.
130 results